Rodney Glenn Mcdonald

Array ( [id] => 11016792 [patent_doc_number] => 20160213745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION' [patent_app_type] => utility [patent_app_number] => 14/978289 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37140 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14978289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14390849 [patent_doc_number] => 10308694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-04 [patent_title] => ProNGF mutants and uses thereof in the production of beta-NGF [patent_app_type] => utility [patent_app_number] => 14/978407 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 16 [patent_no_of_words] => 10695 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14978407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13719907 [patent_doc_number] => 20170370908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => BRAIN IN VITRO MODELS, DEVICES, SYSTEMS, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/536310 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8821 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16304157 [patent_doc_number] => 10772928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Modulation and detection of a neuronal alternative splicing regulatory network for treatment and diagnosis of neurological disorders [patent_app_type] => utility [patent_app_number] => 15/536416 [patent_app_country] => US [patent_app_date] => 2015-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 48 [patent_no_of_words] => 40474 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10729625 [patent_doc_number] => 20160075775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'TREATMENT OF TRAUMATIC BRAIN INJURY USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID' [patent_app_type] => utility [patent_app_number] => 14/953329 [patent_app_country] => US [patent_app_date] => 2015-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24048 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14953329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11962112 [patent_doc_number] => 20170266265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/529468 [patent_app_country] => US [patent_app_date] => 2015-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14080 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10728326 [patent_doc_number] => 20160074475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/947164 [patent_app_country] => US [patent_app_date] => 2015-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23323 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14947164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10792986 [patent_doc_number] => 20160139142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO' [patent_app_type] => utility [patent_app_number] => 14/944311 [patent_app_country] => US [patent_app_date] => 2015-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12322 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14944311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12023680 [patent_doc_number] => 20170313779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'METHODS AND COMPOSITIONS PERTAINING TO HUMAN CEREBRAL CAVERNOUS MALFORMATIONS' [patent_app_type] => utility [patent_app_number] => 15/523521 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 11908 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17323776 [patent_doc_number] => 11214772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Production method for retinal tissue [patent_app_type] => utility [patent_app_number] => 15/521387 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28150 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17323775 [patent_doc_number] => 11214771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Production method for nerve tissue [patent_app_type] => utility [patent_app_number] => 15/521334 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 36 [patent_no_of_words] => 59663 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10760668 [patent_doc_number] => 20160106821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'FUNCTIONAL GHRELIN RECEPTOR ANTAGONISM DURING PREGNANCY TO PREVENT STRESS-ASSOCIATED MENTAL ILLNESS IN OFFSPRING AND MOTHERS' [patent_app_type] => utility [patent_app_number] => 14/887573 [patent_app_country] => US [patent_app_date] => 2015-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8956 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14887573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10774786 [patent_doc_number] => 20160120942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'STABLE NEURAL STEM CELLS COMPRISING AN EXOGENOUS POLYNUCLEOTIDE CODING FOR A GROWTH FACTOR AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/886272 [patent_app_country] => US [patent_app_date] => 2015-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16071 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14886272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10686249 [patent_doc_number] => 20160032393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'METHODS AND KITS FOR PREDICTING PROGNOSIS OF MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 14/882580 [patent_app_country] => US [patent_app_date] => 2015-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27277 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10670884 [patent_doc_number] => 20160017029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/875457 [patent_app_country] => US [patent_app_date] => 2015-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15885 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11943277 [patent_doc_number] => 20170247428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'Chimeric Antigen Receptors' [patent_app_type] => utility [patent_app_number] => 15/511026 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 15125 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13053781 [patent_doc_number] => 10048276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Methods and kits for detecting misfolded proteins [patent_app_type] => utility [patent_app_number] => 14/849670 [patent_app_country] => US [patent_app_date] => 2015-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27334 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11979336 [patent_doc_number] => 20170283490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'NANOBODIES SUITABLE FOR NEURON REGENERATION THERAPY' [patent_app_type] => utility [patent_app_number] => 15/508486 [patent_app_country] => US [patent_app_date] => 2015-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25385 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11011039 [patent_doc_number] => 20160207991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'Therapeutic Antibody' [patent_app_type] => utility [patent_app_number] => 14/842422 [patent_app_country] => US [patent_app_date] => 2015-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 40957 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14852219 [patent_doc_number] => 10414821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-17 [patent_title] => Anti-PD-1 antibody and use thereof [patent_app_type] => utility [patent_app_number] => 15/328462 [patent_app_country] => US [patent_app_date] => 2015-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8103 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328462 [rel_patent_id] =>[rel_patent_doc_number] =>)